Motion for Sanctions Details True Hedge Fund Motives

Hours ago, Celgene filed its Motion for Sanctions against the Coalition for Affordable Drugs in IPR2015-01092, 1096, 1002, and 1103. The Patent Trial and Appeal Board (PTAB) now has until October 28th to decide the issue. As I have maintained all along, these filings will be bounced. The system is already strained under the intense demand for PTAB trial proceedings. The limited resources of the agency can’t be wasted on stock trading schemes.  

A copy of the motion is found (here).